Journal
CURRENT MEDICINAL CHEMISTRY
Volume 29, Issue 37, Pages 5895-5902Publisher
BENTHAM SCIENCE PUBL LTD
DOI: 10.2174/0929867329666220607162250
Keywords
Aptasensor; releasing protein; PCA3; aptamer; cancer cell; biomarker
Funding
- FAPESP, Brazil [2019/13411-5]
Ask authors/readers for more resources
This study aims to develop a new aptasensor for detecting PCA3 release by prostate cancer cells. The stable and sensitive sensors show a wide linear detection range, providing in-depth knowledge about prostate cancer dynamics and offering potential for earlier clinical diagnosis.
Background: Prostate cancer cells have very high PCA3 messenger RNA levels, which turns them into one of the new biomarkers for prostate cancer prognosis and diagnosis. Objective: Our goal here is to develop a new aptasensor to detect PCA3 release by the cancer cell. Methods: DNA hairpin containing PCA3 aptamer was thiolated, conjugated to methylene blue (MB) redox probe, and immobilized on gold electrode through self-assembly to detect label-free cancer cells. Results: Our data have evidenced stable and sensitive sensors presenting a wide linear detection range (0-150ng/mL). In addition, monitoring PCA3 released by different types of prostate cells can provide in-depth knowledge about prostate cancer dynamics; therefore, it is a powerful platform for earlier clinical diagnostic. The released PCA3 can vary depending on the type of adopted prostate cells. Conclusion: PCA3 release was monitored in a group of cells for 2 h; it showed significantly higher expression in both LNCaP and PC-3 cells. This strategy provides a unique and simple methodology to achieve more sensitive and specific PCA3 detection; thus, it emerged as a promising tool for early cost-effective diagnosis
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available